Product
Gemcitabine+Abraxane
1 clinical trial
1 indication
Indication
Pancreatic CancerClinical trial
An Exploratory Clinical Study of Safety and Efficacy of Neoantigen mRNA Vaccines in the Treatment of Patients With Resectable Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-12-01